1. Home
  2. JFIN vs MBOT Comparison

JFIN vs MBOT Comparison

Compare JFIN & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JFIN

Jiayin Group Inc.

SELL

Current Price

$1.44

Market Cap

71.7M

Sector

Finance

ML Signal

SELL

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$0.65

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFIN
MBOT
Founded
2011
2010
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
73.2M
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
JFIN
MBOT
Price
$1.44
$0.65
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $5.38
AVG Volume (30 Days)
591.0K
★ 836.4K
Earning Date
11-27-2026
11-27-2026
Dividend Yield
★ 58.39%
N/A
EPS Growth
N/A
★ 60.27
EPS
★ N/A
N/A
Revenue
N/A
★ $116,887.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$377.83
P/E Ratio
$1.35
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$0.93
52 Week High
$8.83
$2.86

Technical Indicators

Market Signals
Indicator
JFIN
MBOT
Relative Strength Index (RSI) 42.39 24.79
Support Level $1.21 N/A
Resistance Level $1.43 $1.18
Average True Range (ATR) 0.16 0.09
MACD -0.01 -0.02
Stochastic Oscillator 14.85 18.97

Price Performance

Historical Comparison
JFIN
MBOT

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Share on Social Networks: